Sai Parenterals IPO Lists at ₹392 After 1.08x Subscription
By HDFC SKY | Published at: Apr 2, 2026 01:02 PM IST
Sai Parenterals IPO lists at ₹392 on BSE, NSE after 1.08x subscription
Mumbai, April 2: Sai Parenterals Limited entered the secondary market on April 2, listing on both the BSE and NSE at ₹392 per share, exactly in line with the upper end of its issue price band.
The ₹408.79 crore IPO, open between March 24 and March 27, 2026, had already signalled a measured investor response during the bidding window.
Sai Parenterals IPO Subscription Status
The issue closed with an overall subscription of 1.08 times as of March 27, 2026.
Not weak, but not aggressive either. Participation remained selective.
Category-wise Sai Parenterals IPO Subscription Status
| Category | Subscription (times) |
| QIB | 1.34x |
| NII (HNI) | 2.46x |
| Retail | 0.12x |
| Total | 1.08x |
The demand pattern was uneven.
Non-institutional investors showed the strongest interest, while qualified institutional buyers offered moderate support. Retail participation, however, remained notably thin, leaving the segment significantly under-subscribed.
Sai Parenterals Day’s Wise Subscription Summary
| Day | Total Subscription |
| Day 1 | Tepid start |
| Day 2 | Gradual build-up |
| Day 3 | 1.08x |
Momentum built slowly. Most bids came in late.
Sai Parenterals IPO Timeline
| Event | Date |
| Issue Open Date | March 24, 2026 |
| Issue Close Date | March 27, 2026 |
| Basis of Allotment | March 30, 2026 |
| Initiation of Refunds | April 1, 2026 |
| Credit of Shares | April 1, 2026 |
| Listing Date | April 2, 2026 |
Brief Overview Of The IPO
The Sai Parenterals IPO comprised a fresh issue of ₹285 crore alongside an offer for sale of ₹123.79 crore, aggregating to ₹408.79 crore.
Shares were priced between ₹372 and ₹392, with the final issue price fixed at ₹392 per share. The lot size was set at 38 shares.
Sai Parenterals operates in the pharmaceutical manufacturing space, with a focus on injectable formulations and associated healthcare products.
With its shares now listed at the issue price, the company begins its journey in the public markets without any immediate re-rating on debut.
Source:
- https://www.nseindia.com/get-quote/equity/SAIPARENT/Sai-Parenterals-Limited
- https://www.nseindia.com/market-data/all-upcoming-issues-ipo
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
